Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment-Reference-Cited by-同舟云学术

Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment

Published:2012-03 Issue:3 Volume:180 Page:1283-1293
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Akiyama Kosuke,Ohga Noritaka,Hida Yasuhiro,Kawamoto Taisuke,Sadamoto Yoshihiro,Ishikawa Shuhei,Maishi Nako,Akino Tomoshige,Kondoh Miyako,Matsuda Aya,Inoue Nobuo,Shindoh Masanobu,Hida Kyoko

Funder

Ministry of Education, Culture, Sports, Science and Technology

AIAA Foundation

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference56 articles.

1. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat Med,1995

2. Role of angiogenesis in tumor growth and metastasis;Folkman;Semin Oncol,2002

3. Angiogenesis assays: problems and pitfalls;Auerbach;Cancer Metastasis Rev,2000

4. Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches;Kerbel;Cancer Metastasis Rev,2001

5. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer;Browder;Cancer Res,2000

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paracrine signalling in breast cancer: Insights into the tumour endothelial phenotype;Acta Histochemica;2024-10

2. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules;Cancer Letters;2024-06

3. Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer;Proceedings of the National Academy of Sciences;2024-04

4. Aberrant tumor vasculature. Facts and pitfalls;Frontiers in Pharmacology;2024-03-21

5. Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer;2024-03-03